| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |